Form 4 for CAH Cardinal Health
Accepted 2023-08-29 00:00:00 ET · period of report 2023-08-28 · accession 0000721371-23-000082 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-29 | 2023-08-28 | CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | S - Sale+OE | $89.81 | -6,712 | 44.2K | -13% | -$602.8K |
| D | 2023-08-29 | 2023-08-28 | CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | M - OptEx | $71.43 | +6,712 | 50.9K | +15% | +$479.4K |
| D | 2023-08-29 | 2023-08-28 | CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | M - OptEx | $0.00 | -6,712 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-08-28 | S | D | 6,712 | $89.81 | 44,202 | D | — | — | |
| 2 | Common | Common Shares | 2023-08-28 | M | A | 6,712 | $71.43 | 50,914 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2023-08-28 | M | D | 6,712 | $0.00 | 0 | D | $71.43 · — to 2024-08-15 | 6,712 Common Shares | (F1) Stock option vested in three equal installments on August 15, 2015, August 15, 2016, and August 15, 2017. |